Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PinnacleXon Dec 10, 2022 7:47pm
79 Views
Post# 35164233

RE:RE:RE:Santa Paused

RE:RE:RE:Santa Paused
Trogarzon wrote: Being funny...that's the only way to look at this for now.  Honestly how do yo get to this price level even thought no analyst factored  inTh1902  it's target and everyone kept it's targets between 3.25$ and 9$usd.  It's probaly BS to keep the next financing alive with the company.  How do you even begin to explain this situation to clients and fellow sahareholders.  Anyway, it's beyond me how bad a management can be to allow such mutilation of a market cap. I want to hope that the timing and market panic has to do with this death spiral and near death experience but how in the name of Jesus our friend do you become such a market pariah for pausing a trial when it should have been down 50 cents maybe.  Either because it's worse than expected in every possible outcome or you are a bunch of sadistic masochist that can't articulate a rationale for the futur properly.  This behavior is clearly autodestructive atm.   Also, how in the name of my friend Jesus can we be so unsupported by institutions taht should be averaging down or taking advantage of a high volume opportunity considering the thing should be worth more only on cashflow basis iIF they cut expenses (starting with CEO) atm.. No, all in all, something must be done yesterday to safe keep and valorise the assets that remain.  I call on every significant shareholder who can't sell millions of shares at any resoneable level to act and have the board and management execute on their terms in the short to medium time frame an EXIT strategy from this crazy waste of time and money.  It's time to agree that in absence of any pipeline acheivement we must come to realisation that it's worth more than this small change and impose what is called a strategic review plan.  A strategic review plan that focuses on selling the company whole or in parts to maximise shareholder value.  Maximising shareholder value has not happened up to know by wasting 60M in dept we now incur and that has a market value of zero, sorry a negative value at,..  Enough said, take control of this company that has outdone almost every thing I witnessed in my life in terms of incompetence and make  end it now. Otherwise I fear it becomes a study case of corporate strategy in prestigious universities.  That they will have acheived then maybe.  Lets do something now to avoid this from hapening and becoming ourselves Thera roadkills. Amen.

 Ask SPECO he lies to his investors daily, pro at it.  Then he says hes had the best year of his life THIS year, ya. 
<< Previous
Bullboard Posts
Next >>